Trial of potential Ebola antiviral underway, says WH
The World Health Organization has launched a clinical trial called EBO-PEP to test the effectiveness of the antiviral drug obeldesivir in treating people exposed to the Bundibugyo Ebola strain. The trial aims to determine if the drug can prevent high-risk contacts from developing the disease in the Democratic Republic of Congo.
Why it matters
Finding an effective post-exposure treatment for the Bundibugyo Ebola strain could significantly reduce mortality rates in ongoing outbreaks where no approved vaccines currently exist.
Health: Trial of potential Ebola antiviral underway, says WH
The article reports on a medical trial using factual information from the WHO and Gilead Sciences without emotive language.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in